- Andreas C. Dracopoulos Director
Robert Henry Levi and Ryda Hecht Levi Professor of Bioethics and Public Policy
Berman Institute of Bioethics - Professor
Dept. of Health Policy and Management, Johns Hopkins Bloomberg School of Public Health
Jeffrey Kahn, PhD, MPH, is the Andreas C. Dracopoulos Director of the Johns Hopkins Berman Institute of Bioethics, a position he assumed in July 2016. From 2011, he has been the inaugural Robert Henry Levi and Ryda Hecht Levi Professor of Bioethics and Public Policy. He is also Professor in the Dept. of Health Policy and Management of the Johns Hopkins Bloomberg School of Public Health. He works in a variety of areas of bioethics, exploring the intersection of ethics and health/science policy, including human and animal research ethics, public health, and ethical issues in emerging biomedical technologies.
Research Interests
- The intersection of ethics and health/science policy
- Human and animal research ethics
- Public health
- Ethical issues in emerging biomedical technologies.
Education
- PhD, Georgetown University
- MPH, Johns Hopkins Bloomberg School of Public Health
- BA, University of California, Los Angeles
Recent Publications
1. Kahn, JP, Masstroianni, AC. “Sunset on the RAC: When is it Time to End Special Oversight of an Emerging Biotechnology?,” American Journal of Bioethics 18(12):1-2; 2018. DOI: 10.1080/15265161.2018.1540650.
2. Collins, ME, Rum, S, Wheeler, J, et al incl. Kahn J. “Ethical Issues and Recommendations in Grateful Patient Fundraising and Philanthropy,” Academic Medicine 93(11):1631-1637; July 17, 2018; DOI: 10.1097/ACM.0000000000002365.
3. Walker, A, Boyce, A, Geller, G, Thio, CL, Kahn, JP. “Direct-Acting Antivirals and Hepatitis C: The Ethics of Price and Rationing by Genotype (Letter to the Editor),”Clinical Infectious Diseases, 67(6): 983–984; August 31, 2018; https://doi.org/10.1093/cid/ciy239, March 29, 2018.
4. Van Pilsum Rasmussen, SE, Henderson ML, Kahn J, Segev D. “Considering Tangible Benefit for Interdependent Donors: Extending a Risk-Benefit Framework in Donor Selection,” American Journal of Transplantation, e-pub ahead of print DOI: 10.1111/ajt.14319, April 20, 2017.
5. Mathews, DJH, Hester, MD, Kahn JP, et al. “A Conceptual Model for the Translation of Bioethics Research and Scholarship,” Hastings Center Report 46 (2016): 34-39; September-October 2016.
6. Falk, MJ, Decherney A, Kahn JP. “Mitochondrial Replacement Techniques—Implications for the Clinical Community,” New England Journal of Medicine 374:1103-1106; March 24, 2016.